中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
上海药物研究所 [37]
昆明植物研究所 [10]
海洋研究所 [9]
高能物理研究所 [5]
合肥物质科学研究院 [5]
中国科学院大学 [4]
更多
采集方式
OAI收割 [92]
iSwitch采集 [6]
内容类型
期刊论文 [85]
学位论文 [6]
会议论文 [5]
CNKI期刊论文 [2]
发表日期
2024 [3]
2023 [4]
2022 [4]
2021 [7]
2020 [6]
2019 [5]
更多
学科主题
Biochemist... [2]
Oncology [2]
Biochemist... [1]
Cell Biolo... [1]
Chemistry [1]
Chemistry,... [1]
更多
筛选
浏览/检索结果:
共98条,第1-10条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
题名升序
题名降序
提交时间升序
提交时间降序
作者升序
作者降序
发表日期升序
发表日期降序
Berberine attenuates 5-fluorouracil-induced intestinal mucosal injury by modulating the gut microbiota without compromising its anti-tumor efficacy
期刊论文
OAI收割
HELIYON, 2024, 卷号: 10
作者:
Wu, Changhong
;
Yang, Jie
;
Ye, Chenxiao
;
Wu, Hui
;
Shu, Wenxi
  |  
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2024/11/22
5-Fluorouracil
Berberine
Intestinal mucositis
PI3K/AKT/mTOR pathway
Intestinal flora
Vitamin D Relieves Epilepsy Symptoms and Neuroinflammation in Juvenile Mice by Activating the mTOR Signaling Pathway via RAF1: Insights from Network Pharmacology and Molecular Docking Studies
期刊论文
OAI收割
NEUROCHEMICAL RESEARCH, 2024, 页码: 14
作者:
Lu, Tiantian
;
Chen, Xiuling
;
Zhang, Qin
;
Shang, Kun
;
Yang, Xiaogui
  |  
收藏
  |  
浏览/下载:14/0
  |  
提交时间:2024/10/21
Epilepsy
Neuroinflammation
Vitamin D
RAF1
mTOR signaling pathway
Network pharmacology
Molecular docking
Identification of YCH2823 as a novel USP7 inhibitor for cancer therapy
期刊论文
OAI收割
BIOCHEMICAL PHARMACOLOGY, 2024, 卷号: 222, 页码: 11
作者:
Cheng, Yong -Jun
;
Zhuang, Zhen
;
Miao, Yu -Ling
;
Song, Shan -Shan
;
Bao, Xu-Bin
  |  
收藏
  |  
浏览/下载:9/0
  |  
提交时间:2024/05/07
YCH2823
USP7 inhibitor
FT671
BCL6
mTOR inhibitor
AMPK role in epilepsy: a promising therapeutic target?
期刊论文
OAI收割
JOURNAL OF NEUROLOGY, 2023, 页码: 24
作者:
Qi, Yingbei
;
Zhang, Yong-mei
;
Gao, Ya-nan
;
Chen, Wen-gang
;
Zhou, Ting
  |  
收藏
  |  
浏览/下载:93/0
  |  
提交时间:2024/01/26
AMPK
Epilepsy
Neuron Modulation
Metabolism
Ion Channels
mTOR
Effects of salinity training on growth performance, osmotic regulation, and pathogen resistance of post-larval Litopenaeus vannamei
期刊论文
OAI收割
AQUACULTURE, 2023, 卷号: 562, 页码: 10
作者:
Liu, Yuan
;
Wang, Baojie
;
Jiang, Keyong
;
Zhao, Zhiqun
;
Liu, Mei
  |  
收藏
  |  
浏览/下载:43/0
  |  
提交时间:2023/01/06
Compensatory growth
mTOR signaling pathway
Salinity changes
Shrimp nursery farming
Cytostatic Activity of Sanguinarine and a Cyanide Derivative in Human Erythroleukemia Cells Is Mediated by Suppression of c-MET/MAPK Signaling
期刊论文
OAI收割
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 卷号: 24, 期号: 9, 页码: 8113
作者:
Xu,Xinglian
;
Deng,Lulu
;
Tang,Yaling
;
Li,Jiang
;
Zhong,Ting
  |  
收藏
  |  
浏览/下载:11/0
  |  
提交时间:2024/05/09
leukemia
sanguinarine
c-MET
MAPK
PI3K/mTOR
STAT3
MET
二苯乙烯类化合物对胰岛素抵抗HepG2细胞糖脂代谢紊乱的改善作用
期刊论文
OAI收割
中国药理学通报, 2023, 卷号: 39, 期号: 09, 页码: 1746-1754
作者:
马宏婷
;
铁芳芳
;
王瑞楠
;
胡娜
;
王洪伦
  |  
收藏
  |  
浏览/下载:15/0
  |  
提交时间:2023/12/01
二苯乙烯类化合物
HepG2
胰岛素抵抗
糖脂代谢
PPARγ
PI3K/Akt/mTOR1
Targeting Glutamine Metabolism Ameliorates Autoimmune Hepatitis via Inhibiting T Cell Activation and Differentiation
期刊论文
OAI收割
FRONTIERS IN IMMUNOLOGY, 2022, 卷号: 13, 页码: 13
作者:
Yu, Qiang
;
Tu, Honghu
;
Yin, Xueyi
;
Peng, Chang
;
Dou, Chuanyun
  |  
收藏
  |  
浏览/下载:44/0
  |  
提交时间:2022/08/16
glutamine metabolism
autoimmune hepatitis (AIH)
T cells activation and differentiation
mTOR signaling
Antidepressant-like effects of cinnamamide derivative M2 via D-2 receptors in the mouse medial prefrontal cortex
期刊论文
OAI收割
ACTA PHARMACOLOGICA SINICA, 2022, 页码: 9
作者:
Che, Yan-xin
;
Jin, Xiao-yan
;
Xiao, Rong-hua
;
Zhang, Ming
;
Ma, Xiao-hui
  |  
收藏
  |  
浏览/下载:26/0
  |  
提交时间:2022/06/15
depression
D-2 receptor
medial prefrontal cortex
pyramidal neurons
mTOR
TrkB
SAF-248,a novel PI3Kδ-selective inhibitor,potently suppresses the growth of diffuse large B-cell lymphoma
期刊论文
OAI收割
ACTA PHARMACOLOGICA SINICA, 2022, 卷号: 43, 期号: 1, 页码: 209
作者:
Zhang Xi
;
Duan Yuting
;
Wang Yi
;
Zhao Xingdong
;
Sun Yiming
  |  
收藏
  |  
浏览/下载:17/0
  |  
提交时间:2023/05/22
PI3K6
PI3K/AKT/mTOR
diffuse large B-cell lymphoma
resistance
combination therapy